Sandu Pharmaceuticals Board Meeting Scheduled for 14th Nov'26 to Approve Q2 Results
Sandu Pharmaceuticals Ltd 路 Intimation 路 14 Nov 2026, 5:30 am
Sandu Pharmaceuticals Board Meeting Scheduled for 14th Nov'26 to Approve Q2 Results Sandu Pharmaceuticals Limited has scheduled a meeting of its Board of Directors on 14th Nov'26 to consider and approve the standalone unaudited financial results for the quarter ended 30th Sep'26. In accordance with SEBI insider trading regulations, the trading window for dealing in company securities has been closed for directors, officers, and designated employees from 1st Oct'26 and will remain shut until 48 hours post the public announcement of the quarterly results.
Original exchange filing (PDF)
More announcements from Sandu Pharmaceuticals Ltd
- statement of deviation and variation of funds for q ended 30th sept 2026 路 15 Nov 2026
- Results for Q and half year ended 30th sept 2026 路 15 Nov 2026
- Outcome of the Board Meeting dated 14th November 2026 路 15 Nov 2026
- Intimation about change in name of Director from Dr Neeti Madan Kapre to Dr Neeti Gupta 路 09 Oct 2026
- Intimation to the holders of Physical Securities to furnish PAN and KYC details 路 30 Sept 2026
- 1. Redesignation of shri Balram Viswanathan (DIN :10245195)as Chairman and Managing Director of the company. 2.Appointment of Dr Smt Neeti Kapre (DIN:06801264)as Non Executive Independent Director 路 12 Sept 2026
- Appointment of M/s Dave & Dave Chartered Accountant as Statutory Auditor of the Company approved by shareholders in 41st Annual General Meeting 路 12 Sept 2026
- 41st Annual General Meeting scrutinizers Report 路 12 Sept 2026
